Trial
NCT03829566
Autologous Transplant To End NMO Spectrum Disorder
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Northwestern University
Collaborators
—
Condition
Neuromyelitis Optica
Intervention
Rituximab
Why stopped
Discontinued by Investigator
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-11-20